Cymbalta Fibromyalgia sNDA Could Make Lilly Product Lyrica’s First Competitor
Patients treated with Cymbalta show greater reduction in pain compared to placebo in a six-month pivotal trial, Lilly reports.
Patients treated with Cymbalta show greater reduction in pain compared to placebo in a six-month pivotal trial, Lilly reports.